MITCHELL WHITE: Open Payments
NPI 1801208939 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 4 payments from 4 companies in 2025. Trend: 2023 $13 · 2024 $115 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Braeburn Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: INGREZZA, HETLIOZ, BRIXADI, CAPLYTA.
Industry payments across PA — which companies pay providers there.
